# A Study of MK-8527 in Healthy Lactating Female Participants (MK-8527-009)

> **NCT06580587** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 13 (actual)

## Conditions studied

- Healthy
- HIV Pre-exposure Prophylaxis

## Interventions

- **DRUG:** MK-8527

## Key facts

- **NCT ID:** NCT06580587
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-04-15
- **Primary completion:** 2026-03-27
- **Final completion:** 2026-03-27
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06580587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06580587, "A Study of MK-8527 in Healthy Lactating Female Participants (MK-8527-009)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06580587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*